Publications found:
55,956
Sort by:
2013 Endocrine Function Testing Market in France: Hospitals and Commercial Labs
US$ 1,960.00
... Ab and TSH. During the next five years, the endocrine function testing market will undergo significant transformation. These changes will ... , such as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in France: Hospitals and Commercial Labs” is a unique ...
June 2013
269 pages
2013 Endocrine Function Testing Market in Germany: Hospitals, Commercial Labs, Physician Offices
US$ 1,960.00
... new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in Germany: Hospitals, Commercial Labs, Physician Offices” is a unique market and technology assessment designed to help current suppliers ...
June 2013
271 pages
2013 Endocrine Function Testing Market in Italy: Hospitals and Commercial Labs
US$ 1,960.00
... Ab and TSH. During the next five years, the endocrine function testing market will undergo significant transformation. These changes will ... , such as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in Italy : Hospitals and Commercial Labs” is a unique ...
June 2013
269 pages
2013 Endocrine Function Testing Market in Japan: Hospitals and Commercial Labs
US$ 2,200.00
... TPO Ab and TSH. During the next five years, the endocrine function testing market will undergo significant transformation. These changes will ... , such as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in Japan: Hospitals and Commercial Labs” is a unique ...
June 2013
269 pages
2013 Endocrine Function Testing Market in the UK: Hospitals and Commercial Labs
US$ 1,960.00
... Ab and TSH. During the next five years, the endocrine function testing market will undergo significant transformation. These changes will ... , such as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in the UK: Hospitals and Commercial Labs” is a unique ...
June 2013
269 pages
2013 Endocrine Function Testing Market in the US: Hospitals, Commercial Labs, Physician Offices
US$ 2,800.00
... new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in the US: Hospitals, Commercial Labs, Physician Offices” is a unique market and technology assessment designed to help current suppliers ...
June 2013
271 pages
2013 Therapeutic Drug Monitoring (TDM) Market in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
... Acid and Vancomycin. During the next five years, the TDM market will undergo significant transformation. These changes will be caused ... as specimen preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in the US: Hospitals, Commercial Labs, Physician Offices, ...
June 2013
291 pages
2013 Therapeutic Drug Monitoring (TDM) Market in France: Hospitals and Commercial Labs
US$ 1,960.00
... preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in France: Hospitals and Commercial Labs” is a unique market and ... responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors. ...
June 2013
247 pages
2013 Therapeutic Drug Monitoring (TDM) Market in Italy: Hospitals and Commercial Labs
US$ 1,960.00
... preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in Italy: Hospitals and Commercial Labs” is a unique market and ... responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors. ...
June 2013
247 pages
2013 Therapeutic Drug Monitoring (TDM) Market in Japan: Hospitals and Commercial Labs
US$ 2,200.00
... preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in Japan: Hospitals and Commercial Labs” is a unique market and ... responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors. ...
June 2013
247 pages
2013 Therapeutic Drug Monitoring (TDM) Market in the UK: Hospitals and Commercial Labs
US$ 1,960.00
... as specimen preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in the UK: Hospitals and Commercial Labs” is a unique ... responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors ...
June 2013
247 pages
2013 Immunoprotein Diagnostic Testing in Europe: Hospital, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
... for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Immunoprotein Diagnostic Testing in the Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers” is a unique market and technology ...
June 2013
273 pages
2013 Immunoprotein Diagnostic Testing in France: Hospitals and Commercial Labs
US$ 1,960.00
... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Immunoprotein Diagnostic Testing in France: Hospitals and Commercial Labs” is a unique market and technology assessment designed to help current suppliers and potential ...
June 2013
234 pages
2013 Immunoprotein Diagnostic Testing in Germany: Hospitals, Commercial Labs, Physician Offices
US$ 1,960.00
... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Immunoprotein Diagnostic Testing in Germany Hospitals, Commercial Labs, Physician Offices” is a unique market and technology assessment designed to help current suppliers and ...
June 2013
236 pages
2013 Immunoprotein Diagnostic Testing in Italy: Hospitals and Commercial Labs
US$ 1,960.00
... variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Immunoprotein Diagnostic Testing in Italy: Hospitals and Commercial Labs” is a unique market and technology assessment designed to help current suppliers and potential ...
June 2013
233 pages
2013 Immunoprotein Diagnostic Testing in Japan: Hospitals and Commercial Labs
US$ 2,200.00
... variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Immunoprotein Diagnostic Testing in Japan: Hospitals and Commercial Labs” is a unique market and technology assessment designed to help current suppliers and potential ...
June 2013
234 pages
2013 Immunoprotein Diagnostic Testing in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers
US$ 1,960.00
... variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Immunoprotein Diagnostic Testing in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers” is a unique market and technology assessment designed to help current ...
June 2013
236 pages
2013 Immunoprotein Diagnostic Testing in the UK: Hospitals and Commercial Labs
US$ 1,960.00
... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Immunoprotein Diagnostic Testing in the UK: Hospitals and Commercial Labs” is a unique market and technology assessment designed to help current suppliers and potential ...
June 2013
234 pages
2013 Immunoprotein Diagnostic Testing in the US: Hospitals, Commercial Labs, Physician Offices
US$ 2,800.00
... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Immunoprotein Diagnostic Testing in the US: Hospitals, Commercial Labs, Physician Offices” is a unique market and technology assessment designed to help current suppliers and ...
June 2013
236 pages
2013 Analysis of the US Point-of-Care Clinical Chemistry Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 4,400.00
... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major clinical chemistry reagent and ...
May 2013
373 pages
2013 Analysis of the US Point-of-Care Coagulation Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 4,400.00
... hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major coagulation reagent and instrument ...
May 2013
418 pages
2013 Analysis of the US Point-of-Care Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 4,400.00
... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major hematology and flow cytometry ...
May 2013
238 pages
2013 Analysis of the US PT and APTT Point-of-Care Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 2,320.00
... hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major reagent and instrument suppliers. ...
May 2013
337 pages
POC Lipid Testing Market in the US: Physician Offices, Emergency Rooms, Ambulatory Care Centers
US$ 2,320.00
... Planning Group contains 22 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, ... for new instruments and reagent systems with potentially significant market appeal during the next five years. Design criteria for ...
May 2013
305 pages
2013 Analysis of the US Point-of-Care Infectious Disease Diagnostics Market: Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers
US$ 4,400.00
... and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of five POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test ...
May 2013
795 pages
Competing in the US Point-of-Care Diagnostic Testing Market
US$ 13,200.00
... market segment: Home/Personal Testing Physician Offices/Group Practices Emergency Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers and by test category: Routine and Special Chemistry Microbiology/Infectious Diseases ...
May 2013
1172 pages
Diagnostic Testing in the US Ancillary Hospital Locations (ER, OR, ICU)
US$ 10,000.00
... among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient. Market Segmentation Analysis ... during the next ten years. Design criteria for POC testing products. Alternative business expansion strategies. Potential market entry barriers ...
May 2013
973 pages
Microbiology in Europe: Market Segment Forecasts and Supplier Shares
US$ 15,760.00
... opportunities and developing effective business strategies. The report provides market segmentation analysis of over 70 diseases and viruses in five countries, assessment of ... the main driving forces behind the growth of this dynamic market is continuous spread of AIDS, which remains the world’s major health ...
May 2013
1600 pages
Nucleic Acid Testing in Europe: Market Segment Forecasts and Supplier Shares
US$ 15,760.00
... next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies ...
May 2013
970 pages
Transfusion Diagnostics in Europe: Market Segment Forecasts and Supplier Shares
US$ 15,760.00
... from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than ...
May 2013
600 pages
Tumor Markers in Europe: Market Segment Forecasts and Supplier Shares
US$ 15,760.00
... and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in France, Germany, ... diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and ...
May 2013
820 pages
Diagnostic Testing in France: Market Segment Forecasts and Supplier Shares
US$ 3,880.00
... Planning Group provides an overview of the French diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers ... volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and ...
May 2013
58 pages
Diagnostic Testing in Germany: Market Segment Forecasts and Supplier Shares
US$ 3,880.00
... Planning Group provides an overview of the German diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers ... volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and ...
May 2013
61 pages
Diagnostic Testing in Italy: Market Segment Forecasts and Supplier Shares
US$ 3,880.00
... from Venture Planning Group provides an overview of the Italian diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...
May 2013
57 pages
Diagnostic Testing in Japan: Market Segment Forecasts and Supplier Shares
US$ 3,880.00
... from Venture Planning Group provides an overview of the Japanese diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...
May 2013
60 pages
Diagnostic Testing in Spain: Market Segment Forecasts and Supplier Shares
US$ 3,880.00
... from Venture Planning Group provides an overview of the Spanish diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...
May 2013
56 pages
Diagnostic Testing in the UK: Market Segment Forecasts and Supplier Shares
US$ 3,880.00
This new report from Venture Planning Group provides an overview of the UK diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer ...
May 2013
64 pages
Diagnostic Testing in the US: Market Segment Forecasts and Supplier Shares
US$ 4,320.00
This new report from Venture Planning Group provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer ...
May 2013
101 pages